Market Closed -
Hong Kong S.E.
04:08:08 2024-04-02 am EDT
|
5-day change
|
1st Jan Change
|
23.45
HKD
|
-.--%
|
|
-.--%
|
+3.08%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
14,721
|
16,947
|
25,369
|
22,824
|
27,675
|
27,375
|
Enterprise Value (EV)
1 |
19,289
|
20,737
|
29,473
|
26,690
|
30,950
|
30,301
|
P/E ratio
|
22.7
x
|
14.9
x
|
13.5
x
|
13.9
x
|
39.2
x
|
108
x
|
Yield
|
1.62%
|
1.97%
|
2.22%
|
2.63%
|
1.74%
|
0.44%
|
Capitalization / Revenue
|
0.99
x
|
1.05
x
|
1.54
x
|
1.22
x
|
1.43
x
|
1.37
x
|
EV / Revenue
|
1.3
x
|
1.29
x
|
1.78
x
|
1.43
x
|
1.59
x
|
1.52
x
|
EV / EBITDA
|
9.72
x
|
8.08
x
|
8.7
x
|
8.59
x
|
15.2
x
|
18.1
x
|
EV / FCF
|
41.2
x
|
30.9
x
|
-117
x
|
43
x
|
25.5
x
|
37.5
x
|
FCF Yield
|
2.42%
|
3.24%
|
-0.85%
|
2.32%
|
3.92%
|
2.67%
|
Price to Book
|
1.69
x
|
1.79
x
|
2.17
x
|
1.75
x
|
2.31
x
|
2.37
x
|
Nbr of stocks (in thousands)
|
1,194,852
|
1,195,103
|
1,199,474
|
1,201,265
|
1,203,275
|
1,203,285
|
Reference price
2 |
12.32
|
14.18
|
21.15
|
19.00
|
23.00
|
22.75
|
Announcement Date
|
3/10/19
|
3/11/20
|
4/12/21
|
4/21/22
|
4/11/23
|
3/28/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
14,879
|
16,074
|
16,512
|
18,676
|
19,418
|
19,999
|
EBITDA
1 |
1,984
|
2,568
|
3,388
|
3,106
|
2,033
|
1,671
|
EBIT
1 |
1,095
|
1,591
|
2,386
|
2,010
|
881
|
460.2
|
Operating Margin
|
7.36%
|
9.9%
|
14.45%
|
10.76%
|
4.54%
|
2.3%
|
Earnings before Tax (EBT)
1 |
797.7
|
1,371
|
2,326
|
1,950
|
746.9
|
287.6
|
Net income
1 |
649.3
|
1,138
|
1,874
|
1,638
|
706
|
253.2
|
Net margin
|
4.36%
|
7.08%
|
11.35%
|
8.77%
|
3.64%
|
1.27%
|
EPS
2 |
0.5430
|
0.9520
|
1.562
|
1.363
|
0.5869
|
0.2100
|
Free Cash Flow
1 |
467.7
|
672.1
|
-251
|
620.5
|
1,214
|
808.3
|
FCF margin
|
3.14%
|
4.18%
|
-1.52%
|
3.32%
|
6.25%
|
4.04%
|
FCF Conversion (EBITDA)
|
23.57%
|
26.17%
|
-
|
19.98%
|
59.7%
|
48.36%
|
FCF Conversion (Net income)
|
72.03%
|
59.04%
|
-
|
37.87%
|
171.88%
|
319.28%
|
Dividend per Share
2 |
0.2000
|
0.2800
|
0.4700
|
0.5000
|
0.4000
|
0.1000
|
Announcement Date
|
3/10/19
|
3/11/20
|
4/12/21
|
4/21/22
|
4/11/23
|
3/28/24
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
---|
Net sales
1 |
4,106
|
5,486
|
-
|
9,737
|
-
|
9,929
|
EBITDA
1 |
-
|
800
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
478.5
|
-
|
49.6
|
-
|
286.6
|
Operating Margin
|
-
|
8.72%
|
-
|
0.51%
|
-
|
2.89%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
15.18
|
-
|
-
|
Net income
|
266
|
-
|
637.7
|
68.32
|
120.6
|
132.5
|
Net margin
|
6.48%
|
-
|
-
|
0.7%
|
-
|
1.33%
|
EPS
|
-
|
-
|
0.5300
|
-
|
0.1000
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/22/21
|
1/25/22
|
8/19/22
|
1/25/23
|
7/19/23
|
1/24/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
4,568
|
3,790
|
4,104
|
3,866
|
3,275
|
2,926
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.302
x
|
1.476
x
|
1.212
x
|
1.245
x
|
1.611
x
|
1.751
x
|
Free Cash Flow
1 |
468
|
672
|
-251
|
620
|
1,214
|
808
|
ROE (net income / shareholders' equity)
|
7.43%
|
12.5%
|
17.7%
|
13.3%
|
5.64%
|
2.15%
|
ROA (Net income/ Total Assets)
|
3.6%
|
5.19%
|
7.03%
|
5.31%
|
2.27%
|
1.24%
|
Assets
1 |
18,038
|
21,951
|
26,651
|
30,844
|
31,077
|
20,435
|
Book Value Per Share
2 |
7.310
|
7.920
|
9.730
|
10.80
|
9.970
|
9.580
|
Cash Flow per Share
2 |
0.4800
|
0.3900
|
0.6200
|
0.8500
|
0.5000
|
1.140
|
Capex
1 |
1,173
|
1,247
|
1,697
|
1,755
|
1,100
|
1,118
|
Capex / Sales
|
7.89%
|
7.76%
|
10.28%
|
9.4%
|
5.66%
|
5.59%
|
Announcement Date
|
3/10/19
|
3/11/20
|
4/12/21
|
4/21/22
|
4/11/23
|
3/28/24
|
|
1st Jan change
|
Capi.
|
---|
| +3.08% | 3.61B | | +11.26% | 45.67B | | +1.55% | 19.39B | | -12.56% | 3.82B | | +19.82% | 3.06B | | +57.98% | 1.41B | | -25.30% | 1.36B | | +16.85% | 963M | | +12.69% | 742M | | +22.41% | 429M |
Sanitary Products
|